Heterotopic implantation alters the regulation of apoptosis and the cell cycle and generates a new metastatic site in a human pancreatic tumor xenograft model

FASEB Journal

Volumn 16, Issue 9, 2002, Pages 975-982

  Farré, Lourdes ^a   Casanova, Isolda ^a   Guerrero, Sílvia ^a   Trias, Manuel ^a   Capellà, Gabriel ^b   Mangues, Ramon ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Carcinoma; Implantation site; Metastases

Indexed keywords

CASPASE 3; CYCLIN B1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAD; PROTEIN BCL XL; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER TRANSPLANTATION; CELL CYCLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; METASTASIS; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS TUMOR; PRIORITY JOURNAL; TUMOR GROWTH; XENOGRAFT;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; COLON; HUMANS; LIVER; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; ORGAN SPECIFICITY; PANCREAS; PANCREATIC NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; CAPELLA; MUS MUSCULUS;

EID: 0036315010     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-0973com     Document Type: Article

References (39)

1. The microenvironment of the tumour-host interface
2. The influence of the microenvironment on the malignant phenotype
3. Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil
4. Modulation of tumor cell response to chemotherapy by the organ environment
5. Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells
6. Growth dependency of human colon cancer xenograft on organ environment is related with their original clinical stage
7. Efficiency of orthotopic xenograft models for human colon cancers
8. The hallmarks of cancer
9. Recent advances in research on multistage tumorigenesis
10. Suppression of apoptosis: Role in cell growth and neoplasia
11. Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice
12. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination
13. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA
14. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas
15. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease
16. Cancer progression and growth: Relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis
17. Fibronectin, integrins, and growth control
18. Regulation of G1 phase progression by growth factors and the extracellular matrix
19. The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136
20. Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway
21. Rskl mediates a MEK-MAP kinase cell survival signal
22. Underphosphorylated BAD interacts with diverse antiapoptotic Bcl-2 family proteins to regulate apoptosis
23. Mitochondrial control of cell death
24. Mitochondria and cell death
25. MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells
26. Cyclin D1 is a nuclear protein required for cell cycle progression in G1
27. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts
28. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta
29. Isolation of a human cyclin cDNA: Evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2
30. How does the G protein, Gi2, transduce mitogenic signals?
31. Mitogenactivated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts
32. Clinical targets for anti-metastasis therapy
33. The influence of site of metastasis on tumour growth and response to chemotherapy
34. Intrinsic or acquired drug resistance and metastasis: Are they linked phenotypes?
35. An orthotopic mouse model of remetastasis of human colon cancer liver metastasis
36. A nude mouse model of massive liver and lymph node metastasis of human colon cancer
37. Liver colonization competence governs colon cancer metastasis
38. Host organ specifically determines cancer progression